Ikarian Capital »

Rezolute shares owned by Ikarian Capital

Quarter-by-quarter ownership of Rezolute (RZLT) shares owned by Ikarian Capital from 13F filings

Historical chart of Ikarian Capital investment in Rezolute

Tip: Access up to 7 years of quarterly data

All positions including Rezolute held by Ikarian Capital consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Rezolute by Ikarian Capital

Quarter filed Position value Share count Share price at filing
2024-12-31 $4.2M 857k 4.90
2024-09-30 $4.3M 887k 4.85
2024-06-30 $3.9M 904k 4.30

More positions owned by Ikarian Capital

Spdr Ser Tr S&p Biotech Put Option (XBI)
Tyson Foods Cl A Put Option (TSN)
Tarsus Pharmaceuticals (TARS)
Crinetics Pharmaceuticals In (CRNX)
Bridgebio Pharma Call Option (BBIO)
Scholar Rock Hldg Corp Call Option (SRRK)
Amgen Call Option (AMGN)
Insmed Com Par $.01 Call Option (INSM)
Blueprint Medicines (BPMC)
Avidity Biosciences Ord Put Option (RNA)
Sarepta Therapeutics Call Option (SRPT)
Forte Biosciences Com New (FBRX)
Pilgrim's Pride Corporation Put Option (PPC)
Neumora Therapeutics Put Option (NMRA)
Miragen Therapeutics Call Option (VRDN)

View all positions for Ikarian Capital

Top funds holding Rezolute

Federated Investors
Nantahala Capital Management
Vivo Capital
Adage Capital Partners GP
Vanguard Group
Blackstone Group
Altium Capital Management
Affinity Asset Advisors
ADAR1 Capital Management
Ghost Tree Capital
Caxton
Sphera Funds Management
Woodline Partners
Susquehanna International
Ikarian Capital

View all funds holding Rezolute